A Call to Integrate Patient Perspectives in COPD Drug Development
New commentary highlights the need for patient-inspired frameworks to guide COPD therapy development.
New commentary highlights the need for patient-inspired frameworks to guide COPD therapy development.
New commentary highlights the need for patient-inspired frameworks to guide COPD therapy development.
Read MoreResearchers used artificial intelligence to analyze urine samples, accurately forecasting COPD symptom flare-ups seven days before they occurred.
Read MoreA new study suggests that a form of vitamin B3 may be the key to improving quality of life for patients with COPD.
Read MoreOn November 20, the healthcare industry recognizes World COPD Day 2024 with an emphasis on importance of measuring lung function, also known as spirometry.
Read MoreDuring COPD Awareness Month, Olympus Corp of the Americas is celebrating strides in emphysema treatment.
Read MoreThe Global Initiative for Chronic Obstructive Lung Disease (GOLD) has posted a draft of its annual 2025 GOLD Report on COPD diagnosis, management, and prevention.
Read MoreResearchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD.
Read MoreNovember is COPD Awareness Month and the COPD Foundation is working to better inform the community about the disease by debunking common myths.
Read MoreThe startup, selected as the top prize winner by med-tech industry leaders, will use the funding to advance its acoustic resonance patch for COPD.Â
Read MoreRT’s webinar on COPD hospital and home care solutions is now available for on-demand viewing.
Read MoreAdherence to airway clearance therapy in the home is crucial for managing chronic lung conditions, but challenges like time constraints and lack of perceived benefit can hinder patient compliance. Experts offer strategies and new technologies to help improve patients’ adherence.
Read MoreAs COPD progresses, a combination of pathological changes occur in the lungs which necessitate oxygen therapy, which may be delivered in both the acute care and home care settings.
Read MoreResearch predicts that vaping—in addition to smoking and air pollution—will increase the burden of COPD in Western Europe by 2050, while home NIV is expected to reduce mortality from COPD exacerbations.
Read MoreA pilot study suggests that changes in voice patterns recorded via smartphone may help detect early flare-ups in chronic obstructive pulmonary disease.
Read MoreA new study finds individuals with higher genetic risk for COPD show lower lung function starting in childhood.
Read MoreThis live biotherapeutic product, tested in mouse models, shows promise in addressing common pathways of lung disease progression.
Read MoreIncorrectly using inhalers results in poor drug delivery, prompting researchers to call for enhanced education to ensure effective treatment and improve health outcomes.
Read MoreThe COPD Foundation has partnered with Clean Air Dynamics to emphasize the importance of clean air for managing chronic lung diseases and enhancing patient quality of life.
Read MoreThe European Commission has approved Dupixent as an add-on treatment for adults with uncontrolled COPD.
Read MoreThe inhaled therapy for the maintenance treatment of COPD combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule.
Read MoreBoehringer Ingelheim’s new program to cap out-of-pocket costs at $35 per month for eligible patients for the company’s inhalers is now available, according to the company.
Read MoreIdentifying and treating people with previously undiagnosed asthma or COPD led to improved respiratory symptoms, quality of life, and reduced healthcare visits in the year after diagnosis.
Read MoreEliminating racially adjusted spirometry results could lead to a significant increase in Black patient participation in COPD clinical trials, according to findings presented at ATS 2024.
Read MoreNew data presented at ATS 2024 show the potential of Tezspire to play a role in the future treatment of COPD.
Read More